New User? Sign Up | Sign In

Insider Trading - Patterson Matthew R

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Patterson Matthew R

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-11-08
Sale
2019-11-12
5:32 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
14,426 $30 $432,780 113,394
(Indirect
Direct)
View
2019-08-12
Sale
2019-08-14
7:03 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,000 $34.04 $680,835 115,368
(Indirect
Direct)
View
2019-02-25
Sale
2019-02-27
4:31 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
21,000 $30 $630,000 118,700
(Indirect
Direct)
View
2018-10-01
Sale
2018-10-02
7:04 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
21,000 $38.16 $801,372 15,000
(Indirect
Direct)
View
2018-09-18
Sale
2018-09-20
7:01 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
12,952 $40 $518,080 0
(Indirect
Direct)
View
2018-07-02
Sale
2018-07-05
6:34 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
71,048 $39.55 $2,809,837 0
(Indirect
Direct)
View
2018-05-21
Sale
2018-05-23
6:13 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,300 $38.15 $774,498 0
(Indirect
Direct)
View
2018-04-02
Sale
2018-04-04
9:01 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
700 $30.01 $21,009 0
(Indirect
Direct)
View
2017-10-02
Sale
2017-10-04
8:25 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
25,000 $27.92 $698,069 171,814
(Direct
Indirect)
View
2017-09-15
Sale
2017-09-19
6:00 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
10,000 $25.06 $250,561 0
(Indirect
Direct)
View
2017-07-12
Sale
2017-07-14
8:01 pm
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
15,000 $20 $300,059 186,814
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-01-15
Equity Swap
2020-01-15
1:35 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
261,458 $60 0
(Direct)
View
2020-01-15
Equity Swap
2020-01-15
1:35 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
171,814 $60 0
(Indirect)
View
2020-01-15
Disposition
2020-01-15
1:35 pm
N/A
2025-12-18
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
143,569 $9.499 0
(Direct)
View
2020-01-15
Disposition
2020-01-15
1:35 pm
N/A
2027-01-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
188,334 $15.26 0
(Direct)
View
2020-01-15
Disposition
2020-01-15
1:35 pm
N/A
2027-11-16
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
225,000 $27.39 0
(Direct)
View
2020-01-15
Disposition
2020-01-15
1:35 pm
N/A
2029-02-06
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
177,450 $24.74 0
(Direct)
View
2019-12-26
Gift
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
12,500 $0 188,334
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
64,751 $0.78 188,334
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
74,297 $2.19 188,334
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
11,824 $9.5 188,334
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
11,666 $15.26 188,334
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
64,751 $0.78 188,334
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
2025-02-04
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
74,297 $2.19 188,334
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
2025-12-18
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
11,824 $9.5 188,334
(Direct)
View
2019-12-26
Exercise
2020-01-10
6:18 pm
N/A
2027-01-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
11,666 $15.26 188,334
(Direct)
View
2019-12-05
Tax Withholding
2019-12-09
5:16 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
1,974 $59.21 111,420
(Direct)
View
2019-11-08
Exercise
2019-11-12
5:32 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
14,426 $9.5 113,394
(Direct)
View
2019-11-08
Exercise
2019-11-12
5:32 pm
N/A
2025-12-18
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
14,426 $9.5 113,394
(Direct)
View
2019-09-05
Tax Withholding
2019-09-09
4:05 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
1,974 $31.02 113,394
(Direct)
View
2019-08-12
Exercise
2019-08-14
7:03 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,000 $9.5 115,368
(Direct)
View
2019-08-12
Exercise
2019-08-14
7:03 pm
N/A
2025-12-18
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,000 $9.5 115,368
(Direct)
View
2019-06-06
Option Award
2019-06-10
5:10 pm
N/A
2029-06-06
Homology Medicines Inc. FIXX Patterson Matthew R
Director
15,580 $19.51 15,580
(Direct)
View
2019-06-05
Tax Withholding
2019-06-07
4:41 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
3,332 $37.31 115,368
(Direct)
View
2019-02-25
Exercise
2019-02-27
4:31 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
17,000 $0.78 118,700
(Direct)
View
2019-02-25
Exercise
2019-02-27
4:31 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
4,000 $2.19 118,700
(Direct)
View
2019-02-25
Exercise
2019-02-27
4:31 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
17,000 $0.78 118,700
(Direct)
View
2019-02-25
Exercise
2019-02-27
4:31 pm
N/A
2025-02-04
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
4,000 $2.19 118,700
(Direct)
View
2019-02-06
Option Award
2019-02-08
5:50 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
63,700 $0 177,450
(Direct)
View
2019-02-06
Option Award
2019-02-08
5:50 pm
N/A
2029-02-06
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
177,450 $24.74 177,450
(Direct)
View
2018-12-06
Exercise
2018-12-10
4:39 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
40,000 $0.78 31,702
(Direct)
View
2018-12-06
Exercise
2018-12-10
4:39 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
40,000 $0.78 31,702
(Direct)
View
2018-10-01
Exercise
2018-10-02
7:04 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
2,144 $0.78 15,000
(Direct)
View
2018-10-01
Exercise
2018-10-02
7:04 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
5,330 $0.78 15,000
(Direct)
View
2018-10-01
Exercise
2018-10-02
7:04 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
5,448 $0.78 15,000
(Direct)
View
2018-10-01
Exercise
2018-10-02
7:04 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
8,078 $0.78 15,000
(Direct)
View
2018-10-01
Exercise
2018-10-02
7:04 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
21,000 $0.78 15,000
(Direct)
View
2018-09-24
Exercise
2018-09-24
6:12 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
15,000 $0.78 92,702
(Direct)
View
2018-09-24
Exercise
2018-09-24
6:12 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
15,000 $0.78 92,702
(Direct)
View
2018-09-18
Exercise
2018-09-20
7:01 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
12,952 $2.19 0
(Direct)
View
2018-09-18
Exercise
2018-09-20
7:01 pm
N/A
2025-02-04
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
12,952 $2.19 0
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
19,599 $0.78 0
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
1,401 $0.78 0
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
26,901 $0.78 0
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
23,147 $0.78 0
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
19,599 $0.78 0
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
1,401 $0.78 0
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
26,901 $0.78 0
(Direct)
View
2018-07-02
Exercise
2018-07-05
6:34 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
23,147 $0.78 0
(Direct)
View
2018-05-21
Exercise
2018-05-23
6:13 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
13,600 $0.78 0
(Direct)
View
2018-05-21
Exercise
2018-05-23
6:13 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
6,700 $0.78 0
(Direct)
View
2018-05-21
Exercise
2018-05-23
6:13 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
20,300 $0.78 0
(Direct)
View
2018-04-02
Exercise
2018-04-04
9:01 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
700 $0.78 0
(Direct)
View
2018-04-02
Exercise
2018-04-04
9:01 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
700 $0.78 0
(Direct)
View
2018-03-27
Option Award
2018-03-29
7:27 pm
N/A
2028-03-27
Homology Medicines Inc. FIXX Patterson Matthew R
Director
8,360 $16 8,360
(Direct)
View
2017-11-16
Option Award
2017-11-17
5:07 pm
N/A
2027-11-16
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
225,000 $27.39 225,000
(Direct)
View
2017-10-02
Exercise
2017-10-04
8:25 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
10,000 $0.78 171,814
(Direct)
View
2017-10-02
Exercise
2017-10-04
8:25 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
10,000 $0.78 171,814
(Direct)
View
2017-09-15
Exercise
2017-09-19
6:00 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
1,542 $0.78 0
(Direct)
View
2017-09-15
Exercise
2017-09-19
6:00 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
8,458 $0.78 0
(Direct)
View
2017-09-15
Exercise
2017-09-19
6:00 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
1,542 $0.78 0
(Direct)
View
2017-09-15
Exercise
2017-09-19
6:00 pm
N/A
2023-09-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
8,458 $0.78 0
(Direct)
View
2017-01-25
Option Award
2017-01-27
6:09 pm
N/A
2027-01-25
Audentes Therapeutics Inc. BOLD Patterson Matthew R
CEO
200,000 $15.26 200,000
(Direct)
View